Astrazeneca Plc (AZN)
$54.17 0.00 (0.00%)
19:43 EDT AZN Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 137.23B
PE Ratio 48.90
Volume (Avg. Vol.)
Day's Range 54.17 - 54.17
52-Week Range 36.15 - 64.94
Dividend & Yield 1.37 (2.53%)
AZN Stock Predictions, Articles, and Astrazeneca Plc News
- From InvestorPlace
- From the Web
What will the stock market do today? Investors will focus on Warren's wealth tax, EV stocks and Covid-19 hopes. Here's what to know.
The travel and hospitality industry is a sector that should thrive in 2021. In fact, travel is one of Eric Fry's four "Power Trends" in the new year.
Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans.
There’s a lot of potential in the healthcare space thanks to new technologies, and we believe that we have found the best high-quality stocks to play the massive upside.
With growth names still flying high, value stocks to buy doesn’t exactly inspire excitement. Nevertheless, it could be the most prudent choice ahead of an uncertain 2021.
The U.K. greenlighted AstraZeneca's vaccine, but don't take that as a signal to buy. AZN stock looks terrible.
With Pfizer delivering Covid-19 vaccines, PFE stock appears to be the pandemic’s winner. However, a new strain of SARS-CoV-2 and fresh competition may apply some pressure.
The time to pick your horse in the vaccine race was months ago. These stocks were much cheaper before their trials started. Here's where to focus instead.
Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021.
Investors still have a few weeks left of trading, after spectacular returns so far in the year. Here are 7 short-term ideas.
As Pfizer and Moderna take the lead in the novel coronavirus vaccine race, here’s how this affects other Covid-19-related biotech stocks.
Here are pharmaceutical stocks for November 2020 with a focus on companies that are close to delivering a vaccine against Covid-19.
As market valuations look stretched, it's a good time to consider exposure to some low beta safe stocks that feature dependable dividends.
The novel coronavirus pandemic produced some clear winners. And here are seven companies to invest in that adjusted well to the "new normal."
The novel coronavirus and resulting quarantine led a lot of new investors to join in the markets. Here are 10 stocks for beginners to buy.
By Thomas Niel
Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Inovio (NASDAQ:INO) Johnson & Johnson (NYSE:JNJ) Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX)
From The Motley Fool
From Talk Markets
Navellier RatingsPowered by Portfolio Grader